What is the approach to managing hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyponatremia

The approach to managing hyponatremia must be tailored to the patient's volume status (hypovolemic, euvolemic, or hypervolemic), severity of hyponatremia, chronicity, and presence of symptoms. 1 Treatment strategies differ significantly based on these factors, with careful attention to correction rates to prevent osmotic demyelination syndrome.

Initial Assessment and Classification

  1. Determine volume status:

    • Hypovolemic: Signs of dehydration, orthostatic hypotension, dry mucous membranes
    • Euvolemic: No signs of dehydration or fluid overload
    • Hypervolemic: Edema, ascites, fluid overload
  2. Assess severity:

    • Mild: 126-135 mEq/L
    • Moderate: 120-125 mEq/L
    • Severe: <120 mEq/L 2
  3. Evaluate chronicity:

    • Acute: <48 hours
    • Chronic: >48 hours 1
  4. Check for symptoms:

    • Mild symptoms: Nausea, muscle cramps, headache, lethargy
    • Severe symptoms: Confusion, seizures, coma 3

Treatment Algorithm Based on Volume Status

Hypovolemic Hyponatremia

  • First-line treatment: Isotonic (0.9%) saline or 5% albumin 1
  • Discontinue: Diuretics and/or laxatives 2
  • Rate: Infuse at 15-20 mL/kg/hour for first hour, then adjust to 4-14 mL/kg/hour based on clinical response 1

Euvolemic Hyponatremia

  • First-line treatment: Fluid restriction (<1-1.5 L/day) 1
  • For SIADH: Consider salt supplementation (3g/day) if needed 1
  • For severe symptomatic cases: 3% hypertonic saline with careful monitoring 1
  • For chronic SIADH: Consider vasopressin receptor antagonists (tolvaptan), starting at 15 mg once daily, maximum 60 mg daily, for ≤30 days due to liver injury risk 1

Hypervolemic Hyponatremia

  • First-line treatment: Fluid restriction + diuretics 1
  • For cirrhosis:
    • Mild (126-135 mEq/L): Water restriction only
    • Moderate (120-125 mEq/L): Water restriction to 1,000 mL/day and cessation of diuretics
    • Severe (<120 mEq/L): More severe water restriction with albumin infusion 2

Correction Rates and Monitoring

Correction Rate Guidelines

  • Acute hyponatremia (<48 hours): 1 mEq/L/hour 1
  • Chronic hyponatremia (>48 hours): <0.5 mEq/L/hour 1
  • Maximum correction limits:
    • General population: 8-10 mEq/L in 24 hours
    • High-risk patients (cirrhosis, alcoholism, malnutrition): 4-6 mEq/L/day, not exceeding 8 mEq/L in 24 hours 2

Monitoring Protocol

  • Serum sodium: Every 2-4 hours in symptomatic patients 1
  • Electrolytes: Every 4-6 hours initially 1
  • Daily monitoring: Weight to assess fluid status 1

Management of Severe Symptomatic Hyponatremia

  1. Transfer to ICU for close monitoring 1
  2. Administer 3% hypertonic saline with target correction of 6 mmol/L over 6 hours or until severe symptoms resolve 1
  3. Calculate initial infusion rate (mL/kg/hour): Body weight (kg) × desired rate of increase in sodium (mmol/L per hour) 4
  4. If overcorrection occurs: Consider relowering with electrolyte-free water or desmopressin 2

Special Considerations

Cirrhosis

  • Patients with cirrhosis and serum Na ≤130 mEq/L are at increased risk for hepatic encephalopathy, hepatorenal syndrome, and spontaneous bacterial peritonitis 2
  • More conservative correction targets (maximum 8 mEq/L per 24 hours) 2
  • Vasopressin receptor antagonists should be used with caution and only short-term (≤30 days) 2

Prevention of Osmotic Demyelination Syndrome (ODS)

  • High-risk factors: Advanced liver disease, alcoholism, severe malnutrition, severe metabolic derangements (hypophosphatemia, hypokalemia, hypoglycemia), low cholesterol, prior encephalopathy 2
  • If sodium rises too rapidly: Consider desmopressin to prevent further water losses 1
  • Warning: Desmopressin carries a boxed warning for hyponatremia and is contraindicated in patients with hyponatremia or history of hyponatremia 5

Pitfalls to Avoid

  1. Overly rapid correction of chronic hyponatremia, which can lead to osmotic demyelination syndrome 3
  2. Underestimating severity of hyponatremia - even mild hyponatremia is associated with cognitive impairment, gait disturbances, and increased rates of falls and fractures 3
  3. Failing to identify and treat the underlying cause of hyponatremia 6
  4. Using hypotonic fluids in hypovolemic hyponatremia, which can worsen the condition 1
  5. Delaying treatment of severely symptomatic hyponatremia, which is a medical emergency 3

By following this structured approach to hyponatremia management based on volume status, severity, chronicity, and symptoms, clinicians can effectively treat this common electrolyte disorder while minimizing the risk of complications.

References

Guideline

Hyponatremia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.